NextCure, Inc.NXTCNASDAQ
Loading
Enterprise value to EBITDA ratio
Latest
-0.33
↑ 96% vs avg
Percentile
P75
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-8.87
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -0.33 | -8272.2% |
| 2024 | 0.00 | +101.0% |
| 2023 | -0.39 | -44.6% |
| 2022 | -0.27 | +88.1% |
| 2021 | -2.30 | +67.8% |
| 2020 | -7.16 | +70.9% |
| 2019 | -24.58 | -63.3% |
| 2018 | -15.05 | +49.3% |
| 2017 | -29.70 | - |